The smart Trick of pharmaceutical ingredients and excipients That Nobody is Discussing
“As API suppliers, we're a little bit in the center,” Gomes claims. “We see what is going on with our buyers who are generic or branded drug manufacturers, but we also see what is happening in the earliest phase of the provision chain.Procos. Procos, a Cameri, Italy-primarily based CDMO, is investing EUR 17 million ($19 million) to develop it